Haemonetics | HAE - Operating Expenses

Stock Price
59.93
Daily Change
0.31 0.52%
Monthly
7.15%
Yearly
-4.13%
Q2 Forecast
58.65

Haemonetics reported $134.99M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Avanos Medical USD 156.13M 2.7M Dec/2025
Baxter International USD 3.19B 554.4M Dec/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Boston Scientific USD 4.04B 18M Dec/2025
Cerus USD 34.78M 2.98M Dec/2024
Cooper Companies USD 811.3M 113.5M Dec/2025
Fresenius EUR 5.25B 337M Dec/2025
Fresenius Medical Care EUR 4.41B 27.91M Dec/2025
Globus Medical USD 645.11M 241.46M Dec/2025
Haemonetics USD 134.99M 1.26M Dec/2025
ICU Medical USD 514.62M 4.48M Dec/2025
Intuitive Surgical USD 1.91B 89.8M Mar/2026
Masimo USD 328.6M 181.6M Dec/2025
Medtronic USD 7.28B 16M Dec/2025
Merit Medical Systems USD 339.74M 1.8M Dec/2025
Neogen USD 214.5M 15.57M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Plus Therapeutics USD 7.11M 1.23M Dec/2025
Quidel USD 760.9M 1.28B Dec/2025
ResMed USD 925.21M 51.98M Dec/2025
STAAR Surgical USD 68.74M 1.55M Dec/2025
Steris USD 1.22B 28.8M Dec/2025
Stryker USD 5.2B 505M Dec/2025
Surmodics USD 29.51M 274.86M Jun/2025
Teleflex USD 532.64M 3.29B Dec/2025
Terumo JPY 252.74B 22.88B Dec/2025
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
US Physical Therapy USD 185.96M 14.12M Dec/2025
Zimmer Biomet Holdings USD 1.94B 277.8M Dec/2025